Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.

Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as  lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure’s success relies on early detection, accurate staging, and the patient’s overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.

Market Dynamics:

The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.

Key features of the study:

• This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lung cancer surgery  market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lung cancer surgery  market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market

Lung cancer surgery market Detailed Segmentation:

• By Product Type:
  • Surgical Instruments
  • Monitoring & Visualizing System
  • Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems
  • Others
• By Surgery Type:
  • Open Surgery
  • Minimally Invasive Surgery                                                                   
• By Procedure:
  • Lobectomy
  • Segmentectomy/Wedge Resection
  • Pneumonectomy
  • Sleeve Resection
  • Extended Resection
• By Cancer Stage:
  • Early-Stage
  • Advanced-Stage          
• By End user:
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics                                                                                      
• By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Ethicon (Johnson & Johnson)
  • Medtronic
  • Intuitive Surgical
  • Olympus Corporation
  • Karl Storz
  • Accuray Incorporated
  • AngioDynamics
  • Varian Medical Systems
  • Siemens Healthineers
  • Atricure, Inc.
  • Novadaq Technologies Inc.
  • GE Healthcare
  • Scanlan International Inc